Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,250
-650 (-3.85%)
Apr 29, 2026, 11:27 AM KST
Market Cap183.22B +6.8%
Revenue (ttm)195.27B +43.8%
Net Income2.03B
EPS187.00
Shares Out10.84M
PE Ratio90.37
Forward PE16.44
Dividend300.00 (1.76%)
Ex-Dividend DateDec 29, 2025
Volume53,534
Average Volume29,035
Open16,870
Previous Close16,900
Day's Range16,060 - 16,870
52-Week Range14,720 - 20,900
Beta0.73
RSI53.42
Earnings DateMay 15, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

Financial Statements